Talphera (TLPH) Income from Continuing Operations (2010 - 2026)

Talphera's (TLPH) quarterly Income from Continuing Operations came in at 3897000.0 in Q1 2026, down 36.88% year-on-year from 6174045.08 in Q1 2025, and down 3.4% quarter-over-quarter from 3769000.0 in Q4 2025.

Talphera (TLPH) Income from Continuing Operations (2010 - 2026) Analysis & Trends

Talphera's Income from Continuing Operations history runs 17 years deep, the most recent figure standing at 3897000.0 for Q1 2026.

  • On a quarterly basis, Income from Continuing Operations fell 36.88% year-over-year to 3897000.0 in Q1 2026; TTM through Mar 2026 was 14843000.0, a 13.13% decrease from a year earlier, with the FY2025 full-year figure at 85535000.0, up 27.23% from the prior year.
  • Income from Continuing Operations declined to 3897000.0 in Q1 2026 per TLPH's latest filing, from 3769000.0 in the prior quarter.
  • Across five years, Income from Continuing Operations topped out at 74315000.0 in Q2 2022 and bottomed at 15954000.0 in Q4 2022.
  • The 5-year median for Income from Continuing Operations is 3769000.0 (2025), against an average of 46470.59.
  • Biggest YoY gain for Income from Continuing Operations was 854.39% in 2022; the steepest drop was 2843.54% in 2022.
  • Year by year, Income from Continuing Operations stood at 15954000.0 in 2022, then surged by 56.12% to 7000000.0 in 2023, then jumped by 55.81% to 3093000.0 in 2024, then retreated by 21.86% to 3769000.0 in 2025, then decreased by 3.4% to 3897000.0 in 2026.
  • Per Business Quant, the three latest TLPH Income from Continuing Operations figures stand at 3897000.0 (Q1 2026), 3769000.0 (Q4 2025), and 3567000.0 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Continuing) (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 370.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 601.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -3.58 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 274.90 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 176.40 Mn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 197.90 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 57.00 Mn
10 Talphera 47.31 Mn 9.48 Mn - -3.90 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -3.90 Mn
Dec 31, 2025 -3.77 Mn
Sep 30, 2025 -3.57 Mn
Jun 30, 2025 -3.61 Mn
Mar 31, 2025 -2.85 Mn
Dec 31, 2024 -3.09 Mn
Sep 30, 2024 -3.35 Mn
Jun 30, 2024 -3.83 Mn
Mar 31, 2024 -4.02 Mn
Dec 31, 2023 -7.00 Mn
Sep 30, 2023 -1.42 Mn
Jun 30, 2023 -4.43 Mn
Mar 31, 2023 -329,000.00
Dec 31, 2022 -15.95 Mn
Sep 30, 2022 -4.64 Mn
Jun 30, 2022 74.32 Mn
Mar 31, 2022 -9.36 Mn
Dec 31, 2021 -542,000.00
Sep 30, 2021 -8.38 Mn
Jun 30, 2021 -9.85 Mn